We are thrilled to announce that Health Canada has approved Elfabrio (pegunigalsidase alfa) for the treatment of adults with Fabry disease.
Please click here for the press release
The Canadian Fabry Association (CFA) is committed to improving the lives of those who live with and are affected by Fabry disease in Canada.
Registration number 827560871RR0001
Connect with us